In VivoRising Leaders Home Lara Mott, CEO and co-founder of ImproveWell, likens her company’s real-time feedback tool for frontline staff to a smoke detector for health care. The software platform, called t
Generics BulletinThe former leaders of two of the world’s largest generics companies have joined the board of Amneal Pharmaceuticals . Ex-Sandoz divisional head and CEO Jeff George has become a director on the US fir
ScripHaving seen its share price take a hammering as one of the healthcare stocks held by embattled UK fund manager Neil Woodford, Autolus Ltd. has reported that PPF, the investment vehicle controlled by
In VivoAccording to US industry body PhRMA, the average R&D cost of a bringing an FDA-approved drug to patients is around $2.6bn over the past decade, including the cost of the many medicines that do not mak